Judge refuses to delay Glaxo-Human Genome deal

Published



DOVER, Del. (AP) — A federal judge in Delaware has refused to issue a restraining order delaying the acquisition of Human Genome Sciences Inc. by GlaxoSmithKline.

Two HGS shareholders had argued that the tender offer period should be extended beyond Friday’s deadline because Glaxo’s agreement last week to pay $14.25 a share represented a new deal compared to its unsolicited April offer of $13 per share.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.